Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1974 Apr;26(4):703–711.

Protection of rats from experimental allergic encephalomyelitis with antiserum to guinea-pig spinal cord

R A C Hughes
PMCID: PMC1423175  PMID: 4212280

Abstract

Inbred AS rats were immunized with guinea-pig spinal cord. The severity of experimental allergic encephalomyelitis (EAE) was studied in groups treated with antiserum to guinea-pig spinal cord and control groups treated with antiserum to other guinea-pig tissue. Prolonged treatment throughout the experiment strikingly reduced the severity of the clinical disease. Early treatment for the first 8 days after immunization had a similar protective effect. Late treatment starting on the 10th day after immunization did not produce significant protection. Protection was produced by antiserum from both EAE-resistant and EAE-susceptible strains. The protective effect of the serum did not correlate with the presence of haemagglutinating antibodies to basic protein or the titre of complement-fixing antibodies to galactocerebroside. These results suggest that antiserum to undefined central nervous system antigens contains an `enhancing' antibody which inhibits a relatively early stage of the immune response causing EAE.

Full text

PDF
703

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CUNNINGHAM V. R., FIELD E. J. EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PROTECTION EXPERIMENTS WITH ENCEPHALITOGENIC FACTOR AND TUBERCLE FRACTIONS. Ann N Y Acad Sci. 1965 Mar 31;122:346–355. doi: 10.1111/j.1749-6632.1965.tb20219.x. [DOI] [PubMed] [Google Scholar]
  2. Hughes R. A., Stedronska J. The susceptibility of rat strains to experimental allergic encephalomyelitis. Immunology. 1973 May;24(5):879–884. [PMC free article] [PubMed] [Google Scholar]
  3. Leibowitz S., Kennedy L. A., Lessof M. H. Antilymphocyte serum in the later stages of experimental allergic encephalomyelitis. Lancet. 1968 Mar 16;1(7542):569–570. doi: 10.1016/s0140-6736(68)92835-3. [DOI] [PubMed] [Google Scholar]
  4. Lennon V. A., Whittingham S., Carnegie P. R., McPherson T. A., Mackay I. R. Detection of antibodies to the basic protein of human myelin by radioimmunoassay and immunofluorescence. J Immunol. 1971 Jul;107(1):56–62. [PubMed] [Google Scholar]
  5. Levine S., Hoenig E. M., Kies M. W. Allergic encephalomyelitis: immunologically specific inhibition of cellular passive transfer by encephalitogenic basic proteins. Clin Exp Immunol. 1970 Apr;6(4):503–517. [PMC free article] [PubMed] [Google Scholar]
  6. NAKAO A., ROBOZ-EINSTEIN E. CHEMICAL AND IMMUNOCHEMICAL STUDIES WITH A DIALYZABLE ENCEPHALITOGENIC COMPOUND FROM BOVINE SPINAL CORD. Ann N Y Acad Sci. 1965 Mar 31;122:171–181. doi: 10.1111/j.1749-6632.1965.tb20201.x. [DOI] [PubMed] [Google Scholar]
  7. PATERSON P. Y., HARWIN S. M. Suppression of allergic encephalomyelitis in rats by means of antibrain serum. J Exp Med. 1963 May 1;117:755–774. doi: 10.1084/jem.117.5.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Paterson P. Y., Jacobs A. F., Coia E. M. Complement-fixing antibrain antibodies and allergic encephalomyelitis. II. Further studies concerning their protective role. Ann N Y Acad Sci. 1965 Jun 30;124(1):292–298. doi: 10.1111/j.1749-6632.1965.tb18964.x. [DOI] [PubMed] [Google Scholar]
  9. Pokorná Z., Vojtísková M. Nonspecific inhibition of various types of immune response by means of normal serum. Folia Biol (Praha) 1966;12(2):88–96. [PubMed] [Google Scholar]
  10. Rapport M. M., Cavanna R., Graf L. Immunochemical studies of organ and tumour lipids. XVII. The existence of two complement-fixing systems involving cerebroside. J Neurochem. 1967 Jan;14(1):9–18. doi: 10.1111/j.1471-4159.1967.tb09488.x. [DOI] [PubMed] [Google Scholar]
  11. Salvin S. B., Liauw H. L. Immunologic unresponsiveness, immunity and enhancement in experimental allergic encephalomyelitis. J Immunol. 1968 Jul;101(1):33–42. [PubMed] [Google Scholar]
  12. Thiele H. G., Stark R. Antigenic relationship between thymocytes and brain tissue in rats. Lancet. 1971 Oct 16;2(7729):878–879. doi: 10.1016/s0140-6736(71)90256-x. [DOI] [PubMed] [Google Scholar]
  13. Voisin G. A. Immunological facilitation, a broadening of the concept of the enhancement phenomenon. Prog Allergy. 1971;15:328–485. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES